Visualization of Chemokine Binding Sites on Human Brain Microvessels

The chemokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) aid in directing leukocytes to specific locales within the brain and spinal cord during central nervous system inflammation. However, it remains unclear how these chemokines exert their actions across a vascular barrier, raising speculation that interaction with endothelial cells might be required. Therefore, experiments were performed to determine whether binding domains for these chemokines exist along the outer surface of brain microvessels, a feature that could potentially relay chemokine signals from brain to blood. Using a biotinylated chemokine binding assay with confocal microscopy and three-dimensional image reconstruction, spatially resolved binding sites for MCP-1 and MIP-α around human brain microvessels were revealed for the first time. Binding of labeled MCP-1 and MIP-1α could be inhibited by unlabeled homologous but not heterologous chemokine, and was independent of the presence of heparan sulfate, laminin, or collagen in the subendothelial matrix. This is the first evidence of specific and separate binding domains for MCP-1 and MIP-1α on the parenchymal surface of microvessels, and highlights the prospect that specific interactions of chemokines with microvascular elements influence the extent and course of central nervous system inflammation.

[1]  H. Flad,et al.  IL-8 specifically binds to endothelial but not to smooth muscle cells. , 1995, Journal of immunology.

[2]  I. Charo,et al.  The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. , 1996, The Journal of biological chemistry.

[3]  E. Galea,et al.  Choline Acetyltransferase Activity Associated with Cerebral Cortical Microvessels Does Not Originate in Basal Forebrain Neurons , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  A. Sauter,et al.  Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration , 1997, Journal of Neuroimmunology.

[5]  R. Hershkoviz,et al.  Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1 beta. , 1994, Journal of immunology.

[6]  J. Pachter,et al.  Isolation and culture of human brain microvessel endothelial cells for the study of blood-brain barrier properties in vitro , 1995, Brain Research.

[7]  R. Ransohoff,et al.  Regulation and function of central nervous system chemokines , 1995, International Journal of Developmental Neuroscience.

[8]  R. Doms,et al.  CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Lightman,et al.  The blood-brain interface , 1990, Eye.

[10]  D. Adams,et al.  Chemokines: leucocyte recruitment and activation cytokines , 1997, The Lancet.

[11]  P. Leder,et al.  The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation , 1995, The Journal of experimental medicine.

[12]  S. Leung,et al.  Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas , 1997, Acta Neuropathologica.

[13]  R. Horuk,et al.  The Promiscuous Chemokine Binding Profile of the Duffy Antigen/Receptor for Chemokines Is Primarily Localized to Sequences in the Amino-terminal Domain (*) , 1995, The Journal of Biological Chemistry.

[14]  E. Butcher Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity , 1991, Cell.

[15]  M. Gimbrone,et al.  Interaction of platelet factor four with cultured vascular endothelial cells. , 1989, Blood.

[16]  P. Proost,et al.  Leukocyte recruitment by monocyte chemotactic proteins (MCPs) secreted by human phagocytes. , 1994, Journal of immunological methods.

[17]  M. Krangel,et al.  Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. , 1992, Critical reviews in immunology.

[18]  R. Offord,et al.  Synthesis and evaluation of fluorescent chemokines labeled at the amino terminal. , 1997, Methods in enzymology.

[19]  M. Norenberg,et al.  Microvessels Isolated from Rat Brain: Localization of Astrocyte Processes by Immunohistochemical Techniques , 1981, Journal of neurochemistry.

[20]  J. Merrill,et al.  Cytokines in inflammatory brain lesions: helpful and harmful , 1996, Trends in Neurosciences.

[21]  D. Adams,et al.  Regulation of leukocyte recruitment by proadhesive cytokines immobilized on endothelial proteoglycan. , 1993, Current topics in microbiology and immunology.

[22]  H. Lassmann,et al.  Microglial cells are a component of the perivascular glia limitans , 1991, Journal of neuroscience research.

[23]  G. Randolph,et al.  A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. , 1995, Journal of immunology.

[24]  D. Adams,et al.  T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ , 1993, Nature.

[25]  B. Wolff,et al.  Some aspects of IL‐8 pathophysiology III: chemokine interaction with endothelial cells , 1996, Journal of leukocyte biology.

[26]  A. Ben-Baruch,et al.  Chemokines: progress toward identifying molecular targets for therapeutic agents. , 1996, Trends in biotechnology.

[27]  Zhaohua Lu,et al.  The Duffy antigen receptor for chemokines: structural analysis and expression in the brain , 1996, Journal of leukocyte biology.

[28]  C. Power,et al.  Glycosaminoglycans mediate cell surface oligomerization of chemokines. , 1997, Biochemistry.

[29]  A. Matsukawa,et al.  IL‐8 is an essential mediator of the increased delayed‐phase vascular permeability in LPS‐induced rabbit pleurisy , 1998, Journal of leukocyte biology.

[30]  R. Ransohoff Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology , 1997, Journal of leukocyte biology.

[31]  R. Ransohoff,et al.  Cutting Edge Commentary: Chemokine Regulation of Experimental Autoimmune Encephalomyelitis: Temporal and Spatial Expression Patterns Govern Disease Pathogenesis , 1998, The Journal of Immunology.

[32]  R. Strieter,et al.  Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells , 1995, Journal of Neuroimmunology.

[33]  V. Perry,et al.  The blood-brain barrier and the inflammatory response. , 1997, Molecular medicine today.

[34]  M. Baggiolini,et al.  Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  I. Romero,et al.  Astrocyte‐endothelial interaction: physiology and pathology , 1992, Neuropathology and applied neurobiology.

[36]  H. Augustin,et al.  Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. , 1998, Biochemical and biophysical research communications.

[37]  P. Allavena,et al.  Receptors, signal transduction, and spectrum of action of monocyte chemotactic protein‐1 and related chemokines , 1995, Journal of leukocyte biology.

[38]  M. Auer,et al.  Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells , 1997, Cell.

[39]  B. Premack,et al.  Chemokine receptors: Gateways to inflammation and infection , 1996, Nature Medicine.

[40]  I. Charo,et al.  The Amino-terminal Extracellular Domain of the MCP-1 Receptor, but Not the RANTES/MIP-1α Receptor, Confers Chemokine Selectivity , 1996, The Journal of Biological Chemistry.

[41]  D. Taub,et al.  Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. , 1995, Journal of immunology.

[42]  R. Ransohoff,et al.  Central Nervous System Chemokine mRNA Accumulation Follows Initial Leukocyte Entry at the Onset of Acute Murine Experimental Autoimmune Encephalomyelitis , 1995, Brain, Behavior, and Immunity.

[43]  E. Ohlstein,et al.  Chemokine Receptors in Human Endothelial Cells , 1998, The Journal of Biological Chemistry.

[44]  A. Lander,et al.  Differential binding of chemokines to glycosaminoglycan subpopulations , 1994, Current Biology.

[45]  G. McFadden,et al.  New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road. , 1997, Biochemical pharmacology.

[46]  A. Rot Binding of neutrophil attractant/activation protein-1 (interleukin 8) to resident dermal cells. , 1992, Cytokine.

[47]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[48]  A. Hurwitz,et al.  Tumor necrosis factor α and transforming growth factor β upregulate astrocyte expression of monocyte chemoattractant protein-1 , 1995, Journal of Neuroimmunology.

[49]  R. Horuk,et al.  The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor , 1995, The Journal of experimental medicine.